Regarding: ‘Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib’...

بواسطة Porta, C
منشور في 2010

Cardiovascular, cerebrovascular, and respiratory changes induced by different types of music in musicians and non‐musicians: the importance of silence

بواسطة Bernardi, L, Porta, C, Sleight, P
منشور في 2006

Sunitinib re-challenge in advanced renal-cell carcinoma

بواسطة Porta, C, Paglino, C, Grünwald, V
الحاوية / القاعدة Br J Cancer (2014)

Immunoadherence and complement in cancer-bearing mice.

بواسطة Porta, C., Villa, M. L., Clerici, E.
منشور في 1978

Inhibition of protein kinase C-alpha isoform enhances the P-glycoprotein expression and the survival of LoVo human colon adenocarcinoma cells to doxorubicin exposure.

بواسطة La Porta, C. A., Dolfini, E., Comolli, R.
منشور في 1998

Nuclear factors specifically bind to upstream sequences of a Xenopus laevis ribosomal protein gene promoter.

بواسطة Carnevali, F, La Porta, C, Ilardi, V, Beccari, E
منشور في 1989

Effective Time Management: Surgery, Research, Service, Travel, Fitness, and Family

بواسطة Porta, C. Rees, Anderson, Michael R., Steele, Scott R.
منشور في 2013

Inhaled sodium cromoglycate to treat cough in advanced lung cancer patients.

بواسطة Moroni, M., Porta, C., Gualtieri, G., Nastasi, G., Tinelli, C.
منشور في 1996

Widespread cardiovascular autonomic dysfunction in primary amyloidosis: does spontaneous hyperventilation have a compensatory role against postural hypotension?

بواسطة Bernardi, L, Passino, C, Porta, C, Anesi, E, Palladini, G, Merlini, G
منشور في 2002

Repeat partial nephrectomy for recurrence of Von Hippel-Lindau-related renal cell carcinoma in an autotransplanted kidney

بواسطة Perri, D., Marchioro, G., Bondonno, G., Maso, G., Porta, C., Volpe, A.
الحاوية / القاعدة Urol Case Rep (2020)

Comparing comparators: a look at control arms in kidney cancer studies over the years

بواسطة Bracarda, S, Porta, C, Sisani, M, Marrocolo, F, Paglino, C, Hamzaj, A, D Buono, S, Sternberg, C N
الحاوية / القاعدة Br J Cancer (2015)

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

بواسطة Procopio, G, Verzoni, E, Bracarda, S, Ricci, S, Sacco, C, Ridolfi, L, Porta, C, Miceli, R, Zilembo, N, Bajetta, E
منشور في 2011

Nursing practice and global refugee migration: initial impressions from an Intergovernmental-Academic Partnership

بواسطة Bampoh, V., Thongkhamkitcharoen, M., Dicker, S., Dalal, W., Frerich, E., Mann, E., Porta, C., Siddons, N., Stauffer, WM, Hoffman, S.J.
الحاوية / القاعدة Int Nurs Rev (2020)

Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis

بواسطة Bracarda, S, Hutson, T E, Porta, C, Figlin, R A, Calvo, E, Grünwald, V, Ravaud, A, Motzer, R, Kim, D, Anak, O, Panneerselvam, A, Escudier, B
منشور في 2012

Prognostic Value of (18)F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel

بواسطة Quaquarini, E., D'Ambrosio, D., Sottotetti, F., Gallivanone, F., Hodolic, M., Baiardi, P., Palumbo, R., Vellani, C., Canevari, C., Bernardo, A., Castiglioni, I., Porta, C., Trifirò, G.
الحاوية / القاعدة Contrast Media Mol Imaging (2019)

First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts

بواسطة Aeppli, S., Schmaus, M., Eisen, T., Escudier, B., Grünwald, V., Larkin, J., McDermott, D., Oldenburg, J., Porta, C., Rini, B.I., Schmidinger, M., Sternberg, C.N., Rothermundt, C., Putora, P.M.
الحاوية / القاعدة ESMO Open (2021)

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

بواسطة Gore, M E, Szczylik, C, Porta, C, Bracarda, S, Bjarnason, G A, Oudard, S, Lee, S-H, Haanen, J, Castellano, D, Vrdoljak, E, Schöffski, P, Mainwaring, P, Hawkins, R E, Crinò, L, Kim, T M, Carteni, G, Eberhardt, W E E, Zhang, K, Fly, K, Matczak, E, Lechuga, M J, Hariharan, S, Bukowski, R
الحاوية / القاعدة Br J Cancer (2015)

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

بواسطة Motzer, R.J., Tannir, N.M., McDermott, D.F., Frontera, O. Arén, Melichar, B., Choueiri, T.K., Plimack, E.R., Barthélémy, P., Porta, C., George, S., Powles, T., Donskov, F., Neiman, V., Kollmannsberger, C.K., Salman, P., Gurney, H., Hawkins, R., Ravaud, A., Grimm, M.-O., Bracarda, S., Barrios, C.H., Tomita, Y., Castellano, D., Rini, B.I., Chen, A.C., Mekan, S., McHenry, M.B., Wind-Rotolo, M., Doan, J., Sharma, P., Hammers, H.J., Escudier, B.
الحاوية / القاعدة N Engl J Med (2018)